Pyroglutamyl-N-terminal prion protein fragments in sheep brain following the development of transmissible spongiform encephalopathies

Frontiers in Molecular Biosciences

Volumn 2, Issue MAR, 2015, Pages

  Gielbert, Adriana ^a   Thorne, Jemma K ^a   Hope, James ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

Author keywords

Amyloid disease; Mass spectrometry; Prions; Pyroglutamate; Strain differentiation

Indexed keywords

EID: 84991801605     PISSN: None     EISSN: 2296889X     Source Type: Journal    
DOI: 10.3389/fmolb.2015.00007     Document Type: Article

References (39)

1. Baldwin, M. A. (2001). Mass spectrometric analysis of prion proteins. Adv. Protein Chem. 57, 29-54. doi: 10.1016/S0065-3233(01)57017-5
2. Baldwin, M. A., Falick, A. M., Gibson, B. W., Prusiner, S. B., Stahl, N., and Burlingame, A. L. (1990). Tandem mass spectrometry of peptides with N-terminal glutamine. Studies on a prion protein peptide. J. Am. Soc. Mass Spectrom. 1, 258-264. doi: 10.1016/1044-0305(90)85043-L
3. Bruce, M. E. (1993). Scrapie strain variation and mutation. Br. Med. Bull. 49, 822-838
4. Carr, S. A., and Biemann, K. (1984). "Identification of posttranslationally modified amino acids in proteins by mass spectrometry". in Methods in Enzymology, eds F. Wold and K. Moldave (Orlando, FL: Elsevier), 29-58
5. Chelius, D., Jing, K., Lueras, A., Rehder, D. S., Dillon, T. M., Vizel, A., et al. (2006). Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal. Chem. 78, 2370-2376. doi: 10.1021/ac051827k
6. Cynis, H., Scheel, E., Saido, T. C., Schilling, S., and Demuth, H. U. (2008). Amyloidogenic processing of amyloid precursor protein: evidence of a pivotal role of glutaminyl cyclase in generation of pyroglutamate-modified amyloid-beta. Biochemistry 47, 7405-7413. doi: 10.1021/bi800250p
7. Cynis, H., Schilling, S., Bodnar, M., Hoffmann, T., Heiser, U., Saido, T. C., et al. (2006). Inhibition of glutaminyl cyclase alters pyroglutamate formation in mammalian cells. Biochim. Biophys. Acta 1764, 1618-1625. doi: 10.1016/j.bbapap.2006.08.003
8. Everest, S. J., Thorne, L., Barnicle, D. A., Edwards, J. C., Elliott, H., Jackman, R., et al. (2006). Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J. Gen. Virol. 87, 471-477. doi: 10.1099/vir.0.81539-0
9. Garden, R. W., Moroz, T. P., Gleeson, J. M., Floyd, P. D., Li, L., Rubakhin, S. S., et al. (1999). Formation of N-pyroglutamyl peptides from N-Glu and N-Gln precursors in Aplysia neurons. J. Neurochem. 72, 676-681. doi: 10.1046/j.1471-4159.1999.0720676.x
10. Gielbert, A., Davis, L. A., Sayers, A. R., Hope, J., Gill, A. C., and Sauer, M. J. (2009). High-resolution differentiation of transmissible spongiform encephalopathy strains by quantitative N-terminal amino acid profiling (N-TAAP) of PK-digested abnormal prion protein. J. Mass Spectrom. 44, 384-396. doi: 10.1002/jms.1516
11. Gielbert, A., Davis, L. A., Sayers, A. R., Tang, Y., Hope, J., and Sauer, M. J. (2013). Quantitative profiling of PrP peptides by high-performance liquid chromatography mass spectrometry to investigate the diversity of prions. Anal. Biochem. 436, 36-44. doi: 10.1016/j.ab.2013.01.015
12. Hope, J., and Kirby, L. (2012). Amyloid and prions: some biochemical investigations of cerebral amyloidosis in mice. Folia Neuropathol. 50, 13-19
13. Hope, J., Morton, L. J., Farquhar, C. F., Multhaup, G., Beyreuther, K., and Kimberlin, R. H. (1986). The major polypeptide of scrapie-associated fibrils (SAF) has the same size, charge distribution and N-terminal protein sequence as predicted for the normal brain protein (PrP). EMBO J. 5, 2591-2597
14. Hope, J., Multhaup, G., Reekie, L. J. D., Kimberlin, R. H., and Beyreuther, K. (1988a). Molecular pathology of scrapie-associated fibril protein (PrP) in mouse brain affected by the ME7 strain of scrapie. Eur. J. Biochem. 172, 271-277. doi: 10.1111/j.1432-1033.1988.tb13883.x
15. Hope, J., Reekie, L. J., Hunter, N., Multhaup, G., Beyreuther, K., White, H., et al. (1988b). Fibrils from brains of cows with new cattle disease contain scrapie-associated protein. Nature 336, 390-392. doi: 10.1038/336390a0
16. Hope, J., Wood, S. C., Birkett, C. R., Chong, A., Bruce, M. E., Cairns, D., et al. (1999). Molecular analysis of ovine prion protein identifies similarities between BSE and an experimental isolate of natural scrapie, CH1641. J. Gen. Virol. 80(Pt 1), 1-4
17. Howells, L. C., Anderson, S., Coldham, N. G., and Sauer, M. J. (2008). Transmissible spongiform encephalopathy strain-associated diversity of N-terminal proteinase K cleavage sites of PrP(Sc) from scrapie-infected and bovine spongiform encephalopathy-infected mice. Biomarkers 13, 393-412. doi: 10.1080/13547500801903719
18. Ishihama, Y., Oda, Y., Tabata, T., Sato, T., Nagasu, T., Rappsilber, J., et al. (2005). Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol. Cell. Proteomics 4, 1265-1272. doi: 10.1074/mcp. M500061-MCP200
19. Jawhar, S., Wirths, O., and Bayer, T. A. (2011a). Pyroglutamate amyloid-beta (Abeta): a hatchet man in Alzheimer disease. J. Biol. Chem. 286, 38825-38832. doi: 10.1074/jbc. R111.288308
20. Jawhar, S., Wirths, O., Schilling, S., Graubner, S., Demuth, H. U., and Bayer, T. A. (2011b). Overexpression of glutaminyl cyclase, the enzyme responsible for pyroglutamate Aβ formation, induces behavioral deficits, and glutaminyl cyclase knock-out rescues the behavioral phenotype in 5XFAD mice. J. Biol. Chem. 286, 4454-4460. doi: 10.1074/jbc. M110.185819
21. Kim, C., Haldiman, T., Surewicz, K., Cohen, Y., Chen, W., Blevins, J., et al. (2012). Small protease sensitive oligomers of PrPSc in distinct human prions determine conversion rate of PrP(C). PLoS Pathog. 8:e1002835. doi: 10.1371/journal.ppat.1002835
22. Kovacs, G. G., Puopolo, M., Ladogana, A., Pocchiari, M., Budka, H., van Duijn, C., et al. (2005). Genetic prion disease: the EUROCJD experience. Hum. Genet. 118, 166-174. doi: 10.1007/s00439-005-0020-1
23. Mallick, P., Schirle, M., Chen, S. S., Flory, M. R., Lee, H., Martin, D., et al. (2007). Computational prediction of proteotypic peptides for quantitative proteomics. Nat. Biotechnol. 25, 125-131. doi: 10.1038/nbt1275
24. Mandal, A. K., and Balaram, P. (2007). Mass spectrometric identification of pyroglutamic acid in peptides following selective hydrolysis. Anal. Biochem. 370, 118-120. doi: 10.1016/j.ab.2007.06.027
25. Manuelidis, L. (2007). A 25 nm virion is the likely cause of transmissible spongiform encephalopathies. J. Cell. Biochem. 100, 897-915. doi: 10.1002/jcb.21090
26. Matos, J. O., Goldblatt, G., Jeon, J., Chen, B., and Tatulian, S. A. (2014). Pyroglutamylated amyloid-beta peptide reverses cross beta-sheets by a prion-like mechanism. J. Phys. Chem. B 118, 5637-5643. doi: 10.1021/jp412743s
27. Momoi, T., Suzuki, M., Titani, K., Hisanaga, S., Ogawa, H., and Saito, A. (1995). Amino acid sequence of a modified beta 2-microglobulin in renal failure patient urine and long-term dialysis patient blood. Clin. Chim. Acta 236, 135-144. doi: 10.1016/0009-8981(95)06039-G
28. Morel, N., Andreoletti, O., Grassi, J., and Clement, G. (2007). Absolute and relative quantification of sheep brain prion protein (PrP) allelic variants by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry. Rapid Commun. Mass Spectrom. 21, 4093-4100. doi: 10.1002/rcm.3317
29. Mori, H., Takio, K., Ogawara, M., and Selkoe, D. J. (1992). Mass spectrometry of purified amyloid beta protein in Alzheimer's disease. J. Biol. Chem. 267, 17082-17086
30. Nussbaum, J. M., Schilling, S., Cynis, H., Silva, A., Swanson, E., Wangsanut, T., et al. (2012). Prion-like behaviour and tau-dependent cytotoxicity of pyroglutamylated amyloid-beta. Nature 485, 651-655. doi: 10.1038/nature11060
31. Portelius, E., Bogdanovic, N., Gustavsson, M. K., Volkmann, I., Brinkmalm, G., Zetterberg, H., et al. (2010). Mass spectrometric characterization of brain amyloid beta isoform signatures in familial and sporadic Alzheimer's disease. Acta Neuropathol. 120, 185-193. doi: 10.1007/s00401-010-0690-1
32. Ryder, S., Dexter, G., Bellworthy, S., and Tongue, S. (2004). Demonstration of lateral transmission of scrapie between sheep kept under natural conditions using lymphoid tissue biopsy. Res. Vet. Sci. 76, 211-217. doi: 10.1016/j.rvsc.2003.11.007
33. Saul, A., Lashley, T., Revesz, T., Holton, J., Ghiso, J. A., Coomaraswamy, J., et al. (2013). Abundant pyroglutamate-modified ABri and ADan peptides in extracellular and vascular amyloid deposits in familial British and Danish dementias. Neurobiol. Aging 34, 1416-1425. doi: 10.1016/j.neurobiolaging.2012.11.014
34. Schilling, S., Lauber, T., Schaupp, M., Manhart, S., Scheel, E., Bohm, G., et al. (2006). On the seeding and oligomerization of pGlu-amyloid peptides (in vitro). Biochemistry 45, 12393-12399. doi: 10.1021/bi0612667
35. Schilling, S., Zeitschel, U., Hoffmann, T., Heiser, U., Francke, M., Kehlen, A., et al. (2008). Glutaminyl cyclase inhibition attenuates pyroglutamate Abeta and Alzheimer's disease-like pathology. Nat. Med. 14, 1106-1111. doi: 10.1038/nm.1872
36. Schlenzig, D., Manhart, S., Cinar, Y., Kleinschmidt, M., Hause, G., Willbold, D., et al. (2009). Pyroglutamate formation influences solubility and amyloidogenicity of amyloid peptides. Biochemistry 48, 7072-7078. doi: 10.1021/bi900818a
37. Stahl, N., Baldwin, M. A., Teplow, D. B., Hood, L., Gibson, B. W., Burlingame, A. L., et al. (1993). Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry 32, 1991-2002. doi: 10.1021/bi00059a016
38. Tang, Y., Gielbert, A., Jacobs, J. G., Baron, T., Andreoletti, O., Yokoyama, T., et al. (2012). All major prion types recognised by a multiplex immunofluorometric assay for disease screening and confirmation in sheep. J. Immunol. Methods 380, 30-39. doi: 10.1016/j.jim.2012.03.004
39. Wirths, O., Breyhan, H., Cynis, H., Schilling, S., Demuth, H.-U., and Bayer, T. A. (2009). Intraneuronal pyroglutamate-Abeta 3-42 triggers neurodegeneration and lethal neurological deficits in a transgenic mouse model. Acta Neuropathol. 118, 487-496. doi: 10.1007/s00401-009-0557-5